You can't manage what you don't measure, and funders need oversight without overreach. Healthcount reports what a funded pathway is actually doing: activation, retention, drift patterns and safety signposting, aggregated and de-identified, with no individual member data exposed.
What proportion of invited members completed their first check-in within 14 days? Early activation is a strong signal of programme viability.
How many members are still active at 8 weeks, 12 weeks, 6 months? Sustained engagement matters more than initial uptake.
28+ day medication gaps and restart rates per 100 member-months. These metrics help quantify discontinuation risk across the cohort.
What's driving friction in the cohort? Appetite return, side-effect issues and dose skipping, distributed across the group rather than attributed to individuals.
How often are people prompted to seek clinical support? This shows the system is working as intended: catching signals and directing people appropriately.
Opt-out rates, opt-out reasons, and typical time spent. If members stop trusting the measurement, these numbers show it first.
GLP-1 programmes are expensive. Without measurement, funders are paying for pathways they cannot see. Healthcount provides the governance data renewal decisions need: not surveillance, but proportionate, privacy-safe measurement of whether maintenance is actually holding.
See example reporting outputs and learn how Healthcount fits into your governance requirements.